-
公开(公告)号：US20230364122A1
公开(公告)日：2023-11-16
申请号：US18132253
申请日：2023-04-07
申请人： IVERIC bio, Inc.
IPC分类号： A61K31/7088 , A61K31/713 , A61K45/06 , C07K16/22 , C12N15/115 , A61K9/14 , A61K39/395 , A61K9/00
CPC分类号： A61K31/7088 , A61K31/713 , A61K45/06 , C07K16/22 , C12N15/115 , A61K9/143 , A61K39/3955 , A61K9/0048 , C12N2310/16 , C12N2310/351 , C07K2317/24 , C12N2310/322 , C12N2310/321 , C07K2317/76 , C12N2320/30 , C07K2317/55 , C12N2310/314 , C12N2320/31 , C12N2310/317
摘要： The present invention relates to methods for treating and preventing ophthalmological disease and disorders, comprising administering Antagonist A or another pharmaceutically acceptable salt thereof, optionally in combination with another treatment, to a subject in need thereof. The present invention also relates to methods for treating and preventing ophthalmological disease and disorders, comprising administering an anti-05 agent (e.g., ARC1905), optionally in combination with another treatment, to a subject in need thereof.
-
公开(公告)号：US20230364123A1
公开(公告)日：2023-11-16
申请号：US18132283
申请日：2023-04-07
申请人： IVERIC bio, Inc.
IPC分类号： A61K31/7088 , A61K31/713 , A61K39/395 , C12N15/115 , A61K45/06 , A61K9/00 , C07K16/22 , A61K9/14
CPC分类号： A61K31/7088 , A61K31/713 , A61K39/3955 , C12N15/115 , A61K45/06 , A61K9/0048 , C07K16/22 , A61K9/143 , C12N2310/16 , C12N2310/351 , C12N2310/317 , C12N2310/314 , C12N2320/31 , C07K2317/24 , C07K2317/55 , C07K2317/76 , C12N2310/321 , C12N2310/322 , C12N2320/30
摘要： The present invention relates to methods for treating and preventing ophthalmological disease and disorders, comprising administering Antagonist A or another pharmaceutically acceptable salt thereof, optionally in combination with another treatment, to a subject in need thereof. The present invention also relates to methods for treating and preventing ophthalmological disease and disorders, comprising administering an anti-C5 agent (e.g., ARC1905), optionally in combination with another treatment, to a subject in need thereof.
-
公开(公告)号：US11273171B2
公开(公告)日：2022-03-15
申请号：US17346556
申请日：2021-06-14
申请人： IVERIC bio, Inc.
IPC分类号： A61K31/7088 , A61K31/713 , A61K39/395 , C12N15/115 , A61K45/06 , A61K9/00 , C07K16/22 , A61K9/14
摘要： The present invention relates to methods for treating and preventing ophthalmological disease and disorders, comprising administering Antagonist A or another pharmaceutically acceptable salt thereof, optionally in combination with another treatment, to a subject in need thereof. The present invention also relates to methods for treating and preventing ophthalmological disease and disorders, comprising administering an anti-C5 agent (e.g., ARC1905), optionally in combination with another treatment, to a subject in need thereof.
-
公开(公告)号：US20190381087A1
公开(公告)日：2019-12-19
申请号：US16434018
申请日：2019-06-06
申请人： IVERIC bio, Inc.
IPC分类号： A61K31/7088 , A61K31/713 , A61K39/395 , C12N15/115 , A61K45/06 , A61K9/00 , C07K16/22 , A61K9/14
摘要： The present invention relates to methods for treating and preventing ophthalmological disease and disorders, comprising administering Antagonist A or another pharmaceutically acceptable salt thereof, optionally in combination with another treatment, to a subject in need thereof. The present invention also relates to methods for treating and preventing ophthalmological disease and disorders, comprising administering an anti-C5 agent (e.g., ARC1905), optionally in combination with another treatment, to a subject in need thereof.
-
公开(公告)号：US12016875B2
公开(公告)日：2024-06-25
申请号：US18132283
申请日：2023-04-07
申请人： IVERIC bio, Inc.
IPC分类号： A61K31/7088 , A61K9/00 , A61K9/14 , A61K31/713 , A61K39/395 , A61K45/06 , C07K16/22 , C12N15/115
CPC分类号： A61K31/7088 , A61K9/0048 , A61K9/143 , A61K31/713 , A61K39/3955 , A61K45/06 , C07K16/22 , C12N15/115 , C07K2317/24 , C07K2317/55 , C07K2317/76 , C12N2310/16 , C12N2310/314 , C12N2310/317 , C12N2310/321 , C12N2310/322 , C12N2310/351 , C12N2320/30 , C12N2320/31 , A61K39/3955 , A61K2300/00 , C12N2310/322 , C12N2310/3533 , C12N2310/321 , C12N2310/3521 , A61K31/713 , A61K2300/00
摘要： The present invention relates to methods for treating and preventing ophthalmological disease and disorders, comprising administering Antagonist A or another pharmaceutically acceptable salt thereof, optionally in combination with another treatment, to a subject in need thereof. The present invention also relates to methods for treating and preventing ophthalmological disease and disorders, comprising administering an anti-C5 agent (e.g., ARC1905), optionally in combination with another treatment, to a subject in need thereof.
-
公开(公告)号：US11491176B2
公开(公告)日：2022-11-08
申请号：US17676811
申请日：2022-02-21
申请人： IVERIC bio, Inc.
IPC分类号： A61K31/7088 , A61K31/713 , A61K39/395 , C12N15/115 , A61K45/06 , A61K9/00 , C07K16/22 , A61K9/14
摘要： The present invention relates to methods for treating and preventing ophthalmological disease and disorders, comprising administering Antagonist A or another pharmaceutically acceptable salt thereof, optionally in combination with another treatment, to a subject in need thereof. The present invention also relates to methods for treating and preventing ophthalmological disease and disorders, comprising administering an anti-C5 agent (e.g., ARC1905), optionally in combination with another treatment, to a subject in need thereof.
-
公开(公告)号：US20220175813A1
公开(公告)日：2022-06-09
申请号：US17676811
申请日：2022-02-21
申请人： IVERIC bio, Inc.
IPC分类号： A61K31/7088 , A61K31/713 , A61K39/395 , C12N15/115 , A61K45/06 , A61K9/00 , C07K16/22 , A61K9/14
摘要： The present invention relates to methods for treating and preventing ophthalmological disease and disorders, comprising administering Antagonist A or another pharmaceutically acceptable salt thereof, optionally in combination with another treatment, to a subject in need thereof. The present invention also relates to methods for treating and preventing ophthalmological disease and disorders, comprising administering an anti-C5 agent (e.g., ARC1905), optionally in combination with another treatment, to a subject in need thereof.
-
公开(公告)号：US20210369757A1
公开(公告)日：2021-12-02
申请号：US17346556
申请日：2021-06-14
申请人： IVERIC bio, Inc.
IPC分类号： A61K31/7088 , A61K31/713 , A61K39/395 , C12N15/115 , A61K45/06 , A61K9/00 , C07K16/22 , A61K9/14
摘要： The present invention relates to methods for treating and preventing ophthalmological disease and disorders, comprising administering Antagonist A or another pharmaceutically acceptable salt thereof, optionally in combination with another treatment, to a subject in need thereof. The present invention also relates to methods for treating and preventing ophthalmological disease and disorders, comprising administering an anti-C5 agent (e.g., ARC1905), optionally in combination with another treatment, to a subject in need thereof.
-
-
-
-
-
-
-
搜索结果
8 条记录 (耗时 0.022 秒)
